Skip to content

Investigating errorless learning and semantic priming in mild cognitive impairment and mild dementia: The M-DeMi study

Investigating errorless learning and semantic priming in mild cognitive impairment and mild dementia: The M-DeMi study - M-DeMi

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46245
Enrollment
30
Registered
2018-11-05
Start date
2018-11-19
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognitieve stoornis in het kader van neurodegeneratie early dementia mild cognitive impairment

Interventions

None listed

Sponsors

Radboud Universiteit Nijmegen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: between 50-85 years of age MCI (amnestic or multi-domain, CDR=0.5) or mild dementia (CDR=1) native Dutch speaker capable of giving informed consent

Exclusion criteria

Exclusion criteria: MCI due to vascular diseases primary progressive aphasia use of psychotropic medication or recreational drugs serious head trauma or brain surgery neurological or psychiatric disorders (other than MCI) claustrophobia (for MRI-study) large or ferromagnetic metal parts in the head (except for a dental wire; for MRI-study) implanted cardiac pacemaker or neurostimulator (for MRI-study)

Design outcomes

Primary

MeasureTime frame
EL: The effect of error frequency on memory performance in amnestic MCI and MD by using a novel errorless learning task in which the occurrence of errors is controlled compared to previous work. SP: To assess lexical access and executive function in semantic priming in amnestic MCI and MD by means of a picture-word verification task.

Secondary

MeasureTime frame
EL: To compare the cognitive profile to the outcome on the EL and TEL condition. SP: To assess brain atrophy of frontal and temporal brain areas (using MRI) as well as structural connectivity of pathways connecting these regions (using DWI) in MCI and MD.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)